The best regulated crypto exchange
Find out why?

Canopy Growth wins UK’s first medical cannabis bulk import licence

By Hazel Davis
October 16, 2019, 9:28 AM GMT
Small
Medium
Large

    Licence grant could boost UK supply for waiting patients

    The world’s largest publicly traded cannabis company, Canopy Growth, has been awarded the first UK licence for bulk imports of medical cannabis, a move that could boost customer confidence in the Canadian business.

    Although Medical cannabis was legalised in the UK in November 2018, patients have been experiencing delays because specialist wholesalers have not been granted licences. Canopy Growth will now be able to store the drug in bulk at its top-secret Buckinghamshire warehouse to send out the next day.

    The news is expected to improve sentiment towards the company, which has suffered from the sudden departure of co-founder and chief executive Bruce Linton back in July.

    The company has also received negative customer feedback and struggled with perceived lack of demand. The cannabis industry has experienced some upheaval in 2019, with a surge in entrants and political and economic instability compounding the rising concerns around vaping products.

    Since 2018 Canopy’s share price has fallen by more than 65 per cent. The company is backed by Corona beer maker Constellation Brands. It is not expected to turn a profit until 2022, while rival Aurora has said it will be profitable in 2020.

    Canopy shares, which hit all-time lows on Friday October 11, rose on the news.

    Tokenised securities are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how tokenised securities and leverage work and whether you can afford to take the high risk of losing your money. Nothing in the above article should be regarded as a recommendation to trade generally, to trade on a particular platform or to trade in a particular asset. Asset prices can go down as well as up and past performance is not a guide to future performance. Investors and traders should thoroughly research an asset or strategy before making any trading or investment decision and if necessary seek professional advice.

        Small
        Medium
        Large
        Subscribe to Currency.com news
        The most beautiful trading app
        google play storeapple store